Nelson Obus
Board Member
Lifecore Biomedical, Inc. \De\ (LFCR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nelson Obus
Nelson Obus is recorded as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR). Lifecore Biomedical, Inc. \De\ reported in an 8-K filed June 5, 2026 that Nelson Obus was appointed Director, effective June 4, 2026. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed November 7, 2022 that Nelson Obus was appointed director, effective November 1, 2022.
“As a result of the foregoing voting results, each of the foregoing directors was elected to the Board of Directors of the Company to serve for a term expiring at the 2027 Annual Meeting and until their successors are duly elected and qualified, with seven such nominees elected by holders of Common Stock and holders of the Series A Preferred Stock, voting together as a single class, and the Series A Preferred Directors elected solely by holders of the Series A Preferred Stock.”
“As a result of the foregoing voting results, each of the foregoing directors was appointed to the Board to serve until the expiration of their respective terms and until their successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2018-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lifecore Biomedical, Inc. \De\
Other people whose current roles at this company are on record from its filings.
- Paul Josephs CEO, Board Member
- Craig A. Barbarosh Chairman
- Katrina L. Houde Chairman, Board Member
- Brian McLaughlin CFO
- John Morberg CFO
- Ryan D. Lake CFO
- Christopher S. Kiper Board Member
- Humberto Antunes Board Member
- Humberto C. Antunes Board Member
- James G. Hall Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.